Replies to post #494530 on NorthWest Biotherapeutics Inc (NWBO)

[Bypassing time]

They could put a few well placed advertisements about NWBO and the “coming future of glioblastoma” treatment in some respected journals. Something to get their name recognition out there and spark interest, they have not. If the end users (oncologists) don’t know anything about it there will be no big rush or push to use it. At this rate it will enter the SOC in 3 or 4 years, maybe, and that’s if the company doesn’t go belly up. Again, make no mistake I’m invested and believe in the science so don’t start the Bs about shorting it and all that crap. BP will be content to sit back and watch them struggle to the point where it becomes a fire sale, they have all the time in the world and finances on their side.

[BigfootOR]

“Your post insinuates NWBO has already had a PR blitz and it has failed.”

That post never said that or insinuates for that matter. For myself, I took it as the Doctors he knows never heard of DCvax. I could be wrong, but I’m sure the medical field does not receive their information from PRs. It is what it is-speculation. For myself, I think July 20th is the best time to release the news, if not, I’ll be selling chunks at a time and walk away from my 6 year journey through this minefield.

[HappyLibrarian]

The community of oncologists is not that large and one of the chief defenses of the NYAS debacle is that it was targeted to that community and was not part of a PR even and that great strides are being made informing oncologists

His post refuted that defense.